100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
4-Methylpiperazine-1-yl-imino Rifamycin O
● In Stock
| Catalogue No.: | VE0010081 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C45H58N4O14 |
| Mol. Weight: | 878.96 g/mol |
Additional information on 4-Methylpiperazine-1-yl-imino Rifamycin O
Parent drug
RifampicinIUPAC Name
31-[(1E)-2-aza-2-(4-methylpiperazinyl)vinyl]-29-aza-7, 20, 22-trihydroxy- 16-methoxy-8, 12, 17, 19, 21, 23, 27-heptamethyl-13, 35-dioxa-4, 11, 28, 34-tetraoxo Spiro[1, 3-dioxolane-2, 27-tetracyclo[23.3.1.1, 4, 7, 0, 5, 28, ]triacontane]a-6, (33), 7, 9, 14, 24, 26, 30-heptaen-18-yl acetateSynonyms
N/ADescription
It is one of impurity present in Rifampicin, Rifampicin is a semisynthetic antibiotic produced from Streptomyces mediterranei, which has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. which organisms inhibit DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. initiation of RNA synthesis. which is used to treat several types of mycobacterial infections including Mycobacterium avium complex, leprosy, and tuberculosis.References
Schonell, M., Dorken, E., & Grzybowski, S. (1972). Rifampin. Canadian Medical Association Journal, 106(7), 783 “786. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940515/Request a Quote
"*" indicates required fields
Other products related to Rifampicin impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
Rifampicin
CAS No. 13292-46-1
Cat No. VE007986
